NRT Smoking Cessation Aids in Brazil
Euromonitor International's NRT Smoking Cessation Aids in Brazil market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 55 | Publication date: May 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
NRT gum; NRT inhalators; NRT lozenges; NRT patches; Other NRT
Table of contents
NRT SMOKING CESSATION AIDS IN BRAZIL : MARKET INSIGHT
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 1 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 2 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 3 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 4 NRT Gum Flavours 2006-2008
Table 5 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 6 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 7 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 8 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - BRAZIL
ACHé LABORATóRIOS FARMACêUTICOS SA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Aché Laboratórios Farmacêuticos SA: Key Facts
Summary 2 Aché Laboratórios Farmacêuticos SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 3 Aché Laboratórios Farmacêuticos SA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 4 Aché Laboratórios Farmacêuticos SA: Competitive Position 2008
BAYER SA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Bayer SA: Key Facts
Summary 6 Bayer SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 7 Bayer SA: Competitive Position 2008
BOEHRINGER INGELHEIM DO BRASIL QUíMICA E FARMACêUTICA LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Key Facts
Summary 9 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 10 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 11 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2008
DM INDúSTRIA FARMACêUTICA LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 12 DM Indústria Farmacêutica Ltda: Key Facts
Summary 13 DM Indústria Farmacêutica Ltda: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 14 DM Indústria Farmacêutica Ltda: Competitive Position 2008
EMS SA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 15 EMS SA: Key Facts
Summary 16 EMS SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 17 EMS SA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 18 EMS SA: Competitive Position 2008
EUROFARMA LABORATóRIO LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 19 Eurofarma Laboratório Ltda: Key Facts
Summary 20 Eurofarma Laboratório Ltda: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 21 Eurofarma Laboratório Ltda: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 22 Eurofarma Laboratório Ltda: Competitive Position 2008
JANSSEN-CILAG FARMACEUTICA LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 23 Janssen-Cilag Farmacêutica Ltda: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 24 Janssen-Cilag Farmacêutica Ltda: Competitive Position 2008
MEDLEY SA INDúSTRIA FARMACêUTICA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 25 Medley SA Indústria Farmacêutica: Key Facts
Summary 26 Medley SA Indústria Farmacêutica: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 27 Medley SA Indústria Farmacêutica: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 28 Medley SA Indústria Farmacêutica: Competitive Position 2008
NYCOMED PHARMA LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 29 Nycomed Pharma Ltda: Key Facts
Summary 30 Nycomed Pharma Ltda: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 31 Nycomed Pharma Ltda: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 32 Nycomed Pharma Ltda: Competitive Position 2008
SANOFI-AVENTIS FARMACêUTICA LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 33 Sanofi-Aventis Farmacêutica Ltda: Key Facts
Summary 34 Sanofi-Aventis Farmacêutica Ltda: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 35 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2008
OTC HEALTHCARE IN BRAZIL
EXECUTIVE SUMMARY
Positive economy indicators push sales of OTC healthcare
New rules for OTC advertising
Hypermarcas acquires DM Indústria Farmacêutica and Farmasa
Further consolidation of drugstores
Slowdown growth in the next two years
KEY TRENDS AND DEVELOPMENTS
Further restriction to advertising of OTC products
Hypermarcas acquires two leading OTC manufacturers
Specific department for OTC products established within ANVISA
Financial crisis affects OTC products
Senior consumers and women over 40 years old attract investment
MARKET INDICATORS
Table 9 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 10 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 11 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 12 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 13 OTC Healthcare Company Shares by Value 2004-2008
Table 14 OTC Healthcare Brand Shares by Value 2005-2008
Table 15 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 16 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 17 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 18 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
De-reimbursement
Advertising
Packaging and labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 36 OTC Healthcare Switches 2005-2007
DEFINITIONS
Summary 37 Research Sources